NG2 antigen is a therapeutic target for MLLrearranged Bcell acute lymphoblastic leukemia

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

06:04 EST 12 Jan 2019 | Nature Publishing

More From BioPortfolio on "NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia"